Literature DB >> 11746220

Cancer: the evolved consequence of a destabilized genome.

G R Anderson1, D L Stoler, B M Brenner.   

Abstract

The genome is a stable repository of vastly intricate genetic information developed over eons of evolution; this information is replicated at the highest fidelity and expressed within each cell at the highest selectivity. Non-leukemia cancers break this standard; the intricate genetic information qualitatively and progressively deteriorates, resulting in a somatic Darwinian free-for-all. In a process lasting several years, a genomically heterogeneous population replicates from a single cell that originally lost the ability to preserve its genomic integrity. Cells selected for their abilities to proliferate and spread, while evading host defenses, inexorably expand their numbers. The clinical consequences of this become severe, as the genomically diverse cell population that evolves contains members that can evade most therapeutic approaches aimed at "the tumor cell". Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11746220     DOI: 10.1002/bies.1149

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  14 in total

Review 1.  Eukaryotic cells and their cell bodies: Cell Theory revised.

Authors:  Frantisek Baluska; Dieter Volkmann; Peter W Barlow
Journal:  Ann Bot       Date:  2004-05-20       Impact factor: 4.357

2.  The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study.

Authors:  J Chaudhary; M Schmidt
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

3.  Uniparentalism in sporadic colorectal cancer is independent of imprint status, and coordinate for chromosomes 14 and 18.

Authors:  Huferesh K Darbary; Smitha S Dutt; Sheila J Sait; Norma J Nowak; Roy E Heinaman; Daniel L Stoler; Garth R Anderson
Journal:  Cancer Genet Cytogenet       Date:  2009-03

4.  Derivation and characterization of an extra-axial chordoma cell line (EACH-1) from a scapular tumor.

Authors:  Amalia M DeComas; Patrice Penfornis; Michael R Harris; Mark S Meyer; Radhika R Pochampally
Journal:  J Bone Joint Surg Am       Date:  2010-05       Impact factor: 5.284

5.  aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABL.

Authors:  Jeremy D Bartos; Daniel P Gaile; Devin E McQuaid; Jeffrey M Conroy; Huferesh Darbary; Norma J Nowak; Annemarie Block; Nicholas J Petrelli; Arnold Mittelman; Daniel L Stoler; Garth R Anderson
Journal:  Mutat Res       Date:  2007-01-02       Impact factor: 2.433

6.  Targeted destruction of DNA replication protein Cdc6 by cell death pathways in mammals and yeast.

Authors:  Frederic Blanchard; Michael E Rusiniak; Karuna Sharma; Xiaolei Sun; Ivan Todorov; M Mar Castellano; Crisanto Gutierrez; Heinz Baumann; William C Burhans
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

7.  Conditional coalescent trees with two mutation rates and their application to genomic instability.

Authors:  Mathieu Emily; Olivier François
Journal:  Genetics       Date:  2005-12-30       Impact factor: 4.562

Review 8.  Aberrant crypt foci as precursors in colorectal cancer progression.

Authors:  Frank A Orlando; Dongfeng Tan; Juan D Baltodano; Thaer Khoury; John F Gibbs; Victor J Hassid; Bestoun H Ahmed; Sadir J Alrawi
Journal:  J Surg Oncol       Date:  2008-09-01       Impact factor: 3.454

9.  Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.

Authors:  Smitha S Dutt; Neng Chen; Huferesh K Darbary; Helen Swede; Nicholas J Petrelli; Daniel L Stoler; Garth R Anderson
Journal:  Mutat Res       Date:  2008-08-20       Impact factor: 2.433

10.  Noise-induced bistability in the fate of cancer phenotypic quasispecies: a bit-strings approach.

Authors:  Josep Sardanyés; Tomás Alarcón
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.